Medicinal Radiocompounds refer to a specialized class of medicines that contain radionuclides for medical diagnosis and treatment. These compounds or biological preparations are labeled with radionuclides and used for diagnosing or treating medical conditions within the body. Medicinal Radiocompounds work by binding radioisotopes to biomolecules, allowing them to target specific organs, tissues, or cells. They play a crucial role in medical imaging and therapeutic interventions, particularly in oncology and cardiology.
Market Size
The global Medicinal Radiocompounds market was valued at approximately USD 6,761 million in 2024 and is projected to reach USD 13,742.20 million by 2032, exhibiting a CAGR of 8.20% over the forecast period. North America, a key regional market, accounted for USD 2,018.07 million in 2024, with a projected CAGR of 7.03% from 2025 through 2032.
The rising adoption of radiopharmaceuticals in medical imaging and therapy, coupled with advancements in nuclear medicine, is expected to drive market growth significantly.
Market Dynamics (Drivers, Restraints, Opportunities, and Challenges)
Drivers
-
Growing Prevalence of Cancer and Cardiovascular Diseases: The increasing incidence of cancer and heart diseases has led to a rising demand for effective diagnostic and treatment methods, boosting the adoption of Medicinal Radiocompounds.
-
Technological Advancements in Nuclear Medicine: Innovations in radiopharmaceuticals and imaging techniques are enhancing diagnostic accuracy and therapeutic effectiveness.
-
Increasing Government and Private Investments: Substantial funding for nuclear medicine research and development is fueling market expansion.
-
Aging Population and Rising Healthcare Expenditure: With a growing elderly population, the demand for diagnostic imaging and targeted therapies is increasing.
Restraints
-
High Cost of Radiopharmaceuticals and Imaging Equipment: The production and usage of Medicinal Radiocompounds require significant investment, limiting their accessibility.
-
Stringent Regulatory Frameworks: Strict government regulations on the production and distribution of radiopharmaceuticals pose challenges to market growth.
-
Short Half-Life of Radiocompounds: The rapid decay of radioactive isotopes limits their usability, requiring efficient production and distribution logistics.
Opportunities
-
Expansion in Emerging Markets: Developing economies, particularly in Asia-Pacific, are witnessing growing healthcare infrastructure, creating new growth opportunities.
-
Advancements in Theranostics: The integration of diagnostic and therapeutic radiopharmaceuticals (theranostics) is revolutionizing personalized medicine.
-
Collaborations and Strategic Partnerships: Increased collaborations between pharmaceutical companies and research institutions are driving innovation in nuclear medicine.
Challenges
-
Limited Availability of Radioisotopes: The global supply chain of key isotopes, such as Technetium-99m, faces constraints, affecting market stability.
-
Lack of Skilled Professionals: The field of nuclear medicine requires specialized expertise, creating a gap in workforce availability.
Regional Analysis
North America
North America is the largest market for Medicinal Radiocompounds, primarily driven by advanced healthcare infrastructure, strong research and development activities, and increasing adoption of nuclear medicine. The U.S. dominates the regional market, with major companies and research institutions investing heavily in radiopharmaceuticals.
Europe
Europe holds a significant share of the global market, with countries like Germany, the UK, and France leading in radiopharmaceutical research. The presence of regulatory bodies such as the European Medicines Agency (EMA) ensures quality control and safety in nuclear medicine.
Asia-Pacific
The Asia-Pacific region is experiencing rapid growth due to increasing healthcare investments, rising awareness about nuclear medicine, and the presence of emerging players in the pharmaceutical industry. Countries such as China, Japan, and India are key contributors to market expansion.
South America, Middle East, and Africa
These regions are gradually adopting Medicinal Radiocompounds, with Brazil and South Africa leading the growth. However, challenges such as limited access to nuclear medicine facilities and regulatory constraints are slowing the pace of adoption.
Competitor Analysis
The global Medicinal Radiocompounds market is highly competitive, with several key players dominating the landscape. Major companies include:
These companies are focusing on mergers, acquisitions, product innovations, and strategic partnerships to enhance their market presence.
Market Segmentation (by Application)
-
Oncology
-
Cardiology
-
Others
Market Segmentation (by Type)
-
Technetium 99
-
Fluorine 18
-
Other
Geographic Segmentation
-
North America (USA, Canada, Mexico)
-
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
-
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
-
South America (Brazil, Argentina, Colombia, Rest of South America)
-
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
FAQ Section
What is the current market size of the Medicinal Radiocompounds market?
The global Medicinal Radiocompounds market was valued at USD 6,761 million in 2024 and is projected to reach USD 13,742.20 million by 2032.
Which are the key companies operating in the Medicinal Radiocompounds market?
Major companies include Bracco Imaging, Bayer, Cardinal Health, Curium Pharma, Novartis, Lantheus, Acrotech Biopharma, GE Healthcare, and China Isotope & Radiation, among others.
What are the key growth drivers in the Medicinal Radiocompounds market?
Key drivers include the increasing prevalence of cancer and cardiovascular diseases, technological advancements in nuclear medicine, rising government investments, and an aging population.
Which regions dominate the Medicinal Radiocompounds market?
North America holds the largest share, followed by Europe and Asia-Pacific, due to strong healthcare infrastructure and research activities.
What are the emerging trends in the Medicinal Radiocompounds market?
Emerging trends include the rise of theranostics, expansion in emerging markets, and increased collaborations for innovation in nuclear medicine
Key Benefits of This Market Research:
-
Industry drivers, restraints, and opportunities covered in the study
-
Neutral perspective on the market performance
-
Recent industry trends and developments
-
Competitive landscape & strategies of key players
-
Potential & niche segments and regions exhibiting promising growth covered
-
Historical, current, and projected market size, in terms of value
-
In-depth analysis of the Medicinal Radiocompounds Market
Overview of the regional outlook of the Medicinal Radiocompounds Market:
Key Reasons to Buy this Report:
-
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
-
This enables you to anticipate market changes to remain ahead of your competitors
-
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
-
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
-
Provision of market value data for each segment and sub-segment
-
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
-
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
-
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
-
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
-
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
-
Includes in-depth analysis of the market from various perspectives through Porters five forces analysis
-
Provides insight into the market through Value Chain
-
Market dynamics scenario, along with growth opportunities of the market in the years to come
-
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
- Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
- Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Medicinal Radiocompounds Market and its likely evolution in the short to mid-term, and long term.
- Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
- Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
- Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
- Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
- Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
- Chapter 8 provides a quantitative analysis of the market size and development potential of each region from the consumer side and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
- Chapter 9 shares the main producing countries of Medicinal Radiocompounds, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
- Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
- Chapter 11 provides a quantitative analysis of the market size and development potential of each region during the forecast period.
- Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment during the forecast period.
- Chapter 13 is the main points and conclusions of the report.
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Medicinal Radiocompounds
1.2 Key Market Segments
1.2.1 Medicinal Radiocompounds Segment by Type
1.2.2 Medicinal Radiocompounds Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Medicinal Radiocompounds Market Overview
2.1 Global Market Overview
2.1.1 Global Medicinal Radiocompounds Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Medicinal Radiocompounds Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Medicinal Radiocompounds Market Competitive Landscape
3.1 Global Medicinal Radiocompounds Sales by Manufacturers (2019-2025)
3.2 Global Medicinal Radiocompounds Revenue Market Share by Manufacturers (2019-2025)
3.3 Medicinal Radiocompounds Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Medicinal Radiocompounds Average Price by Manufacturers (2019-2025)
3.5 Manufacturers Medicinal Radiocompounds Sales Sites, Area Served, Product Type
3.6 Medicinal Radiocompounds Market Competitive Situation and Trends
3.6.1 Medicinal Radiocompounds Market Concentration Rate
3.6.2 Global 5 and 10 Largest Medicinal Radiocompounds Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Medicinal Radiocompounds Industry Chain Analysis
4.1 Medicinal Radiocompounds Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Medicinal Radiocompounds Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Medicinal Radiocompounds Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Medicinal Radiocompounds Sales Market Share by Type (2019-2025)
6.3 Global Medicinal Radiocompounds Market Size Market Share by Type (2019-2025)
6.4 Global Medicinal Radiocompounds Price by Type (2019-2025)
7 Medicinal Radiocompounds Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Medicinal Radiocompounds Market Sales by Application (2019-2025)
7.3 Global Medicinal Radiocompounds Market Size (M USD) by Application (2019-2025)
7.4 Global Medicinal Radiocompounds Sales Growth Rate by Application (2019-2025)
8 Medicinal Radiocompounds Market Consumption by Region
8.1 Global Medicinal Radiocompounds Sales by Region
8.1.1 Global Medicinal Radiocompounds Sales by Region
8.1.2 Global Medicinal Radiocompounds Sales Market Share by Region
8.2 North America
8.2.1 North America Medicinal Radiocompounds Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Medicinal Radiocompounds Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Medicinal Radiocompounds Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Medicinal Radiocompounds Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Medicinal Radiocompounds Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Medicinal Radiocompounds Market Production by Region
9.1 Global Production of Medicinal Radiocompounds by Region (2019-2025)
9.2 Global Medicinal Radiocompounds Revenue Market Share by Region (2019-2025)
9.3 Global Medicinal Radiocompounds Production, Revenue, Price and Gross Margin (2019-2025)
9.4 North America Medicinal Radiocompounds Production
9.4.1 North America Medicinal Radiocompounds Production Growth Rate (2019-2025)
9.4.2 North America Medicinal Radiocompounds Production, Revenue, Price and Gross Margin (2019-2025)
9.5 Europe Medicinal Radiocompounds Production
9.5.1 Europe Medicinal Radiocompounds Production Growth Rate (2019-2025)
9.5.2 Europe Medicinal Radiocompounds Production, Revenue, Price and Gross Margin (2019-2025)
9.6 Japan Medicinal Radiocompounds Production (2019-2025)
9.6.1 Japan Medicinal Radiocompounds Production Growth Rate (2019-2025)
9.6.2 Japan Medicinal Radiocompounds Production, Revenue, Price and Gross Margin (2019-2025)
9.7 China Medicinal Radiocompounds Production (2019-2025)
9.7.1 China Medicinal Radiocompounds Production Growth Rate (2019-2025)
9.7.2 China Medicinal Radiocompounds Production, Revenue, Price and Gross Margin (2019-2025)
10 Key Companies Profile
10.1 Bracco Imaging
10.1.1 Bracco Imaging Medicinal Radiocompounds Basic Information
10.1.2 Bracco Imaging Medicinal Radiocompounds Product Overview
10.1.3 Bracco Imaging Medicinal Radiocompounds Product Market Performance
10.1.4 Bracco Imaging Business Overview
10.1.5 Bracco Imaging Medicinal Radiocompounds SWOT Analysis
10.1.6 Bracco Imaging Recent Developments
10.2 Bayer
10.2.1 Bayer Medicinal Radiocompounds Basic Information
10.2.2 Bayer Medicinal Radiocompounds Product Overview
10.2.3 Bayer Medicinal Radiocompounds Product Market Performance
10.2.4 Bayer Business Overview
10.2.5 Bayer Medicinal Radiocompounds SWOT Analysis
10.2.6 Bayer Recent Developments
10.3 Cardinal Health
10.3.1 Cardinal Health Medicinal Radiocompounds Basic Information
10.3.2 Cardinal Health Medicinal Radiocompounds Product Overview
10.3.3 Cardinal Health Medicinal Radiocompounds Product Market Performance
10.3.4 Cardinal Health Medicinal Radiocompounds SWOT Analysis
10.3.5 Cardinal Health Business Overview
10.3.6 Cardinal Health Recent Developments
10.4 Curium Pharma
10.4.1 Curium Pharma Medicinal Radiocompounds Basic Information
10.4.2 Curium Pharma Medicinal Radiocompounds Product Overview
10.4.3 Curium Pharma Medicinal Radiocompounds Product Market Performance
10.4.4 Curium Pharma Business Overview
10.4.5 Curium Pharma Recent Developments
10.5 Novartis
10.5.1 Novartis Medicinal Radiocompounds Basic Information
10.5.2 Novartis Medicinal Radiocompounds Product Overview
10.5.3 Novartis Medicinal Radiocompounds Product Market Performance
10.5.4 Novartis Business Overview
10.5.5 Novartis Recent Developments
10.6 Lantheus
10.6.1 Lantheus Medicinal Radiocompounds Basic Information
10.6.2 Lantheus Medicinal Radiocompounds Product Overview
10.6.3 Lantheus Medicinal Radiocompounds Product Market Performance
10.6.4 Lantheus Business Overview
10.6.5 Lantheus Recent Developments
10.7 Acrotech Biopharma
10.7.1 Acrotech Biopharma Medicinal Radiocompounds Basic Information
10.7.2 Acrotech Biopharma Medicinal Radiocompounds Product Overview
10.7.3 Acrotech Biopharma Medicinal Radiocompounds Product Market Performance
10.7.4 Acrotech Biopharma Business Overview
10.7.5 Acrotech Biopharma Recent Developments
10.8 GE Healthcare
10.8.1 GE Healthcare Medicinal Radiocompounds Basic Information
10.8.2 GE Healthcare Medicinal Radiocompounds Product Overview
10.8.3 GE Healthcare Medicinal Radiocompounds Product Market Performance
10.8.4 GE Healthcare Business Overview
10.8.5 GE Healthcare Recent Developments
10.9 China Isotope and Radiation
10.9.1 China Isotope and Radiation Medicinal Radiocompounds Basic Information
10.9.2 China Isotope and Radiation Medicinal Radiocompounds Product Overview
10.9.3 China Isotope and Radiation Medicinal Radiocompounds Product Market Performance
10.9.4 China Isotope and Radiation Business Overview
10.9.5 China Isotope and Radiation Recent Developments
10.10 Jubilant Pharma
10.10.1 Jubilant Pharma Medicinal Radiocompounds Basic Information
10.10.2 Jubilant Pharma Medicinal Radiocompounds Product Overview
10.10.3 Jubilant Pharma Medicinal Radiocompounds Product Market Performance
10.10.4 Jubilant Pharma Business Overview
10.10.5 Jubilant Pharma Recent Developments
10.11 Eli Lilly
10.11.1 Eli Lilly Medicinal Radiocompounds Basic Information
10.11.2 Eli Lilly Medicinal Radiocompounds Product Overview
10.11.3 Eli Lilly Medicinal Radiocompounds Product Market Performance
10.11.4 Eli Lilly Business Overview
10.11.5 Eli Lilly Recent Developments
10.12 SIEMENS
10.12.1 SIEMENS Medicinal Radiocompounds Basic Information
10.12.2 SIEMENS Medicinal Radiocompounds Product Overview
10.12.3 SIEMENS Medicinal Radiocompounds Product Market Performance
10.12.4 SIEMENS Business Overview
10.12.5 SIEMENS Recent Developments
10.13 Dongcheng
10.13.1 Dongcheng Medicinal Radiocompounds Basic Information
10.13.2 Dongcheng Medicinal Radiocompounds Product Overview
10.13.3 Dongcheng Medicinal Radiocompounds Product Market Performance
10.13.4 Dongcheng Business Overview
10.13.5 Dongcheng Recent Developments
11 Medicinal Radiocompounds Market Forecast by Region
11.1 Global Medicinal Radiocompounds Market Size Forecast
11.2 Global Medicinal Radiocompounds Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Medicinal Radiocompounds Market Size Forecast by Country
11.2.3 Asia Pacific Medicinal Radiocompounds Market Size Forecast by Region
11.2.4 South America Medicinal Radiocompounds Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Medicinal Radiocompounds by Country
12 Forecast Market by Type and by Application (2025-2032)
12.1 Global Medicinal Radiocompounds Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Medicinal Radiocompounds by Type (2025-2032)
12.1.2 Global Medicinal Radiocompounds Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Medicinal Radiocompounds by Type (2025-2032)
12.2 Global Medicinal Radiocompounds Market Forecast by Application (2025-2032)
12.2.1 Global Medicinal Radiocompounds Sales (K MT) Forecast by Application
12.2.2 Global Medicinal Radiocompounds Market Size (M USD) Forecast by Application (2025-2032)
13 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Medicinal Radiocompounds Market Size Comparison by Region (M USD)
Table 5. Global Medicinal Radiocompounds Sales (K MT) by Manufacturers (2019-2025)
Table 6. Global Medicinal Radiocompounds Sales Market Share by Manufacturers (2019-2025)
Table 7. Global Medicinal Radiocompounds Revenue (M USD) by Manufacturers (2019-2025)
Table 8. Global Medicinal Radiocompounds Revenue Share by Manufacturers (2019-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Medicinal Radiocompounds as of 2022)
Table 10. Global Market Medicinal Radiocompounds Average Price (USD/MT) of Key Manufacturers (2019-2025)
Table 11. Manufacturers Medicinal Radiocompounds Sales Sites and Area Served
Table 12. Manufacturers Medicinal Radiocompounds Product Type
Table 13. Global Medicinal Radiocompounds Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Medicinal Radiocompounds
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Medicinal Radiocompounds Market Challenges
Table 22. Global Medicinal Radiocompounds Sales by Type (K MT)
Table 23. Global Medicinal Radiocompounds Market Size by Type (M USD)
Table 24. Global Medicinal Radiocompounds Sales (K MT) by Type (2019-2025)
Table 25. Global Medicinal Radiocompounds Sales Market Share by Type (2019-2025)
Table 26. Global Medicinal Radiocompounds Market Size (M USD) by Type (2019-2025)
Table 27. Global Medicinal Radiocompounds Market Size Share by Type (2019-2025)
Table 28. Global Medicinal Radiocompounds Price (USD/MT) by Type (2019-2025)
Table 29. Global Medicinal Radiocompounds Sales (K MT) by Application
Table 30. Global Medicinal Radiocompounds Market Size by Application
Table 31. Global Medicinal Radiocompounds Sales by Application (2019-2025) & (K MT)
Table 32. Global Medicinal Radiocompounds Sales Market Share by Application (2019-2025)
Table 33. Global Medicinal Radiocompounds Sales by Application (2019-2025) & (M USD)
Table 34. Global Medicinal Radiocompounds Market Share by Application (2019-2025)
Table 35. Global Medicinal Radiocompounds Sales Growth Rate by Application (2019-2025)
Table 36. Global Medicinal Radiocompounds Sales by Region (2019-2025) & (K MT)
Table 37. Global Medicinal Radiocompounds Sales Market Share by Region (2019-2025)
Table 38. North America Medicinal Radiocompounds Sales by Country (2019-2025) & (K MT)
Table 39. Europe Medicinal Radiocompounds Sales by Country (2019-2025) & (K MT)
Table 40. Asia Pacific Medicinal Radiocompounds Sales by Region (2019-2025) & (K MT)
Table 41. South America Medicinal Radiocompounds Sales by Country (2019-2025) & (K MT)
Table 42. Middle East and Africa Medicinal Radiocompounds Sales by Region (2019-2025) & (K MT)
Table 43. Global Medicinal Radiocompounds Production (K MT) by Region (2019-2025)
Table 44. Global Medicinal Radiocompounds Revenue (US$ Million) by Region (2019-2025)
Table 45. Global Medicinal Radiocompounds Revenue Market Share by Region (2019-2025)
Table 46. Global Medicinal Radiocompounds Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 47. North America Medicinal Radiocompounds Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 48. Europe Medicinal Radiocompounds Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 49. Japan Medicinal Radiocompounds Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 50. China Medicinal Radiocompounds Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 51. Bracco Imaging Medicinal Radiocompounds Basic Information
Table 52. Bracco Imaging Medicinal Radiocompounds Product Overview
Table 53. Bracco Imaging Medicinal Radiocompounds Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 54. Bracco Imaging Business Overview
Table 55. Bracco Imaging Medicinal Radiocompounds SWOT Analysis
Table 56. Bracco Imaging Recent Developments
Table 57. Bayer Medicinal Radiocompounds Basic Information
Table 58. Bayer Medicinal Radiocompounds Product Overview
Table 59. Bayer Medicinal Radiocompounds Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 60. Bayer Business Overview
Table 61. Bayer Medicinal Radiocompounds SWOT Analysis
Table 62. Bayer Recent Developments
Table 63. Cardinal Health Medicinal Radiocompounds Basic Information
Table 64. Cardinal Health Medicinal Radiocompounds Product Overview
Table 65. Cardinal Health Medicinal Radiocompounds Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 66. Cardinal Health Medicinal Radiocompounds SWOT Analysis
Table 67. Cardinal Health Business Overview
Table 68. Cardinal Health Recent Developments
Table 69. Curium Pharma Medicinal Radiocompounds Basic Information
Table 70. Curium Pharma Medicinal Radiocompounds Product Overview
Table 71. Curium Pharma Medicinal Radiocompounds Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 72. Curium Pharma Business Overview
Table 73. Curium Pharma Recent Developments
Table 74. Novartis Medicinal Radiocompounds Basic Information
Table 75. Novartis Medicinal Radiocompounds Product Overview
Table 76. Novartis Medicinal Radiocompounds Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 77. Novartis Business Overview
Table 78. Novartis Recent Developments
Table 79. Lantheus Medicinal Radiocompounds Basic Information
Table 80. Lantheus Medicinal Radiocompounds Product Overview
Table 81. Lantheus Medicinal Radiocompounds Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 82. Lantheus Business Overview
Table 83. Lantheus Recent Developments
Table 84. Acrotech Biopharma Medicinal Radiocompounds Basic Information
Table 85. Acrotech Biopharma Medicinal Radiocompounds Product Overview
Table 86. Acrotech Biopharma Medicinal Radiocompounds Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 87. Acrotech Biopharma Business Overview
Table 88. Acrotech Biopharma Recent Developments
Table 89. GE Healthcare Medicinal Radiocompounds Basic Information
Table 90. GE Healthcare Medicinal Radiocompounds Product Overview
Table 91. GE Healthcare Medicinal Radiocompounds Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 92. GE Healthcare Business Overview
Table 93. GE Healthcare Recent Developments
Table 94. China Isotope and Radiation Medicinal Radiocompounds Basic Information
Table 95. China Isotope and Radiation Medicinal Radiocompounds Product Overview
Table 96. China Isotope and Radiation Medicinal Radiocompounds Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 97. China Isotope and Radiation Business Overview
Table 98. China Isotope and Radiation Recent Developments
Table 99. Jubilant Pharma Medicinal Radiocompounds Basic Information
Table 100. Jubilant Pharma Medicinal Radiocompounds Product Overview
Table 101. Jubilant Pharma Medicinal Radiocompounds Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 102. Jubilant Pharma Business Overview
Table 103. Jubilant Pharma Recent Developments
Table 104. Eli Lilly Medicinal Radiocompounds Basic Information
Table 105. Eli Lilly Medicinal Radiocompounds Product Overview
Table 106. Eli Lilly Medicinal Radiocompounds Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 107. Eli Lilly Business Overview
Table 108. Eli Lilly Recent Developments
Table 109. SIEMENS Medicinal Radiocompounds Basic Information
Table 110. SIEMENS Medicinal Radiocompounds Product Overview
Table 111. SIEMENS Medicinal Radiocompounds Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 112. SIEMENS Business Overview
Table 113. SIEMENS Recent Developments
Table 114. Dongcheng Medicinal Radiocompounds Basic Information
Table 115. Dongcheng Medicinal Radiocompounds Product Overview
Table 116. Dongcheng Medicinal Radiocompounds Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 117. Dongcheng Business Overview
Table 118. Dongcheng Recent Developments
Table 119. Global Medicinal Radiocompounds Sales Forecast by Region (2025-2032) & (K MT)
Table 120. Global Medicinal Radiocompounds Market Size Forecast by Region (2025-2032) & (M USD)
Table 121. North America Medicinal Radiocompounds Sales Forecast by Country (2025-2032) & (K MT)
Table 122. North America Medicinal Radiocompounds Market Size Forecast by Country (2025-2032) & (M USD)
Table 123. Europe Medicinal Radiocompounds Sales Forecast by Country (2025-2032) & (K MT)
Table 124. Europe Medicinal Radiocompounds Market Size Forecast by Country (2025-2032) & (M USD)
Table 125. Asia Pacific Medicinal Radiocompounds Sales Forecast by Region (2025-2032) & (K MT)
Table 126. Asia Pacific Medicinal Radiocompounds Market Size Forecast by Region (2025-2032) & (M USD)
Table 127. South America Medicinal Radiocompounds Sales Forecast by Country (2025-2032) & (K MT)
Table 128. South America Medicinal Radiocompounds Market Size Forecast by Country (2025-2032) & (M USD)
Table 129. Middle East and Africa Medicinal Radiocompounds Consumption Forecast by Country (2025-2032) & (Units)
Table 130. Middle East and Africa Medicinal Radiocompounds Market Size Forecast by Country (2025-2032) & (M USD)
Table 131. Global Medicinal Radiocompounds Sales Forecast by Type (2025-2032) & (K MT)
Table 132. Global Medicinal Radiocompounds Market Size Forecast by Type (2025-2032) & (M USD)
Table 133. Global Medicinal Radiocompounds Price Forecast by Type (2025-2032) & (USD/MT)
Table 134. Global Medicinal Radiocompounds Sales (K MT) Forecast by Application (2025-2032)
Table 135. Global Medicinal Radiocompounds Market Size Forecast by Application (2025-2032) & (M USD)
List of Figures
Figure 1. Product Picture of Medicinal Radiocompounds
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Medicinal Radiocompounds Market Size (M USD), 2019-2032
Figure 5. Global Medicinal Radiocompounds Market Size (M USD) (2019-2032)
Figure 6. Global Medicinal Radiocompounds Sales (K MT) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Medicinal Radiocompounds Market Size by Country (M USD)
Figure 11. Medicinal Radiocompounds Sales Share by Manufacturers in 2023
Figure 12. Global Medicinal Radiocompounds Revenue Share by Manufacturers in 2023
Figure 13. Medicinal Radiocompounds Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Medicinal Radiocompounds Average Price (USD/MT) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Medicinal Radiocompounds Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Medicinal Radiocompounds Market Share by Type
Figure 18. Sales Market Share of Medicinal Radiocompounds by Type (2019-2025)
Figure 19. Sales Market Share of Medicinal Radiocompounds by Type in 2023
Figure 20. Market Size Share of Medicinal Radiocompounds by Type (2019-2025)
Figure 21. Market Size Market Share of Medicinal Radiocompounds by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Medicinal Radiocompounds Market Share by Application
Figure 24. Global Medicinal Radiocompounds Sales Market Share by Application (2019-2025)
Figure 25. Global Medicinal Radiocompounds Sales Market Share by Application in 2023
Figure 26. Global Medicinal Radiocompounds Market Share by Application (2019-2025)
Figure 27. Global Medicinal Radiocompounds Market Share by Application in 2023
Figure 28. Global Medicinal Radiocompounds Sales Growth Rate by Application (2019-2025)
Figure 29. Global Medicinal Radiocompounds Sales Market Share by Region (2019-2025)
Figure 30. North America Medicinal Radiocompounds Sales and Growth Rate (2019-2025) & (K MT)
Figure 31. North America Medicinal Radiocompounds Sales Market Share by Country in 2023
Figure 32. U.S. Medicinal Radiocompounds Sales and Growth Rate (2019-2025) & (K MT)
Figure 33. Canada Medicinal Radiocompounds Sales (K MT) and Growth Rate (2019-2025)
Figure 34. Mexico Medicinal Radiocompounds Sales (Units) and Growth Rate (2019-2025)
Figure 35. Europe Medicinal Radiocompounds Sales and Growth Rate (2019-2025) & (K MT)
Figure 36. Europe Medicinal Radiocompounds Sales Market Share by Country in 2023
Figure 37. Germany Medicinal Radiocompounds Sales and Growth Rate (2019-2025) & (K MT)
Figure 38. France Medicinal Radiocompounds Sales and Growth Rate (2019-2025) & (K MT)
Figure 39. U.K. Medicinal Radiocompounds Sales and Growth Rate (2019-2025) & (K MT)
Figure 40. Italy Medicinal Radiocompounds Sales and Growth Rate (2019-2025) & (K MT)
Figure 41. Russia Medicinal Radiocompounds Sales and Growth Rate (2019-2025) & (K MT)
Figure 42. Asia Pacific Medicinal Radiocompounds Sales and Growth Rate (K MT)
Figure 43. Asia Pacific Medicinal Radiocompounds Sales Market Share by Region in 2023
Figure 44. China Medicinal Radiocompounds Sales and Growth Rate (2019-2025) & (K MT)
Figure 45. Japan Medicinal Radiocompounds Sales and Growth Rate (2019-2025) & (K MT)
Figure 46. South Korea Medicinal Radiocompounds Sales and Growth Rate (2019-2025) & (K MT)
Figure 47. India Medicinal Radiocompounds Sales and Growth Rate (2019-2025) & (K MT)
Figure 48. Southeast Asia Medicinal Radiocompounds Sales and Growth Rate (2019-2025) & (K MT)
Figure 49. South America Medicinal Radiocompounds Sales and Growth Rate (K MT)
Figure 50. South America Medicinal Radiocompounds Sales Market Share by Country in 2023
Figure 51. Brazil Medicinal Radiocompounds Sales and Growth Rate (2019-2025) & (K MT)
Figure 52. Argentina Medicinal Radiocompounds Sales and Growth Rate (2019-2025) & (K MT)
Figure 53. Columbia Medicinal Radiocompounds Sales and Growth Rate (2019-2025) & (K MT)
Figure 54. Middle East and Africa Medicinal Radiocompounds Sales and Growth Rate (K MT)
Figure 55. Middle East and Africa Medicinal Radiocompounds Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Medicinal Radiocompounds Sales and Growth Rate (2019-2025) & (K MT)
Figure 57. UAE Medicinal Radiocompounds Sales and Growth Rate (2019-2025) & (K MT)
Figure 58. Egypt Medicinal Radiocompounds Sales and Growth Rate (2019-2025) & (K MT)
Figure 59. Nigeria Medicinal Radiocompounds Sales and Growth Rate (2019-2025) & (K MT)
Figure 60. South Africa Medicinal Radiocompounds Sales and Growth Rate (2019-2025) & (K MT)
Figure 61. Global Medicinal Radiocompounds Production Market Share by Region (2019-2025)
Figure 62. North America Medicinal Radiocompounds Production (K MT) Growth Rate (2019-2025)
Figure 63. Europe Medicinal Radiocompounds Production (K MT) Growth Rate (2019-2025)
Figure 64. Japan Medicinal Radiocompounds Production (K MT) Growth Rate (2019-2025)
Figure 65. China Medicinal Radiocompounds Production (K MT) Growth Rate (2019-2025)
Figure 66. Global Medicinal Radiocompounds Sales Forecast by Volume (2019-2032) & (K MT)
Figure 67. Global Medicinal Radiocompounds Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Medicinal Radiocompounds Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Medicinal Radiocompounds Market Share Forecast by Type (2025-2032)
Figure 70. Global Medicinal Radiocompounds Sales Forecast by Application (2025-2032)
Figure 71. Global Medicinal Radiocompounds Market Share Forecast by Application (2025-2032)
